-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BnNFt1pQHeZm87KRHbXCzPrRYs1/ffIFEpVZbTBqqQJQPzZ1UCiT0ASXRkkDUjId nw0ZlAwQhdqBpFKGsJSVdA== 0001058809-99-000009.txt : 19990309 0001058809-99-000009.hdr.sgml : 19990309 ACCESSION NUMBER: 0001058809-99-000009 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990308 FILED AS OF DATE: 19990308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOPHARMACEUTICS INC CENTRAL INDEX KEY: 0000733337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133186327 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 5 SEC ACT: SEC FILE NUMBER: 001-09370 FILM NUMBER: 99559462 BUSINESS ADDRESS: STREET 1: 990 STATION RD CITY: BELLPORT STATE: NY ZIP: 11713 BUSINESS PHONE: 5162865800 MAIL ADDRESS: STREET 1: 990 STATION ROAD CITY: BELLPORT STATE: NY ZIP: 11713 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED GENERICS INC /NV/ DATE OF NAME CHANGE: 19880824 FORMER COMPANY: FORMER CONFORMED NAME: PATIENT MEDICAL SYSTEMS CORP DATE OF NAME CHANGE: 19880615 COMPANY DATA: COMPANY CONFORMED NAME: ROSEN JONATHAN CENTRAL INDEX KEY: 0001081252 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 520 S LUCERNE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90020 MAIL ADDRESS: STREET 1: 520 S LUCERNE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90020 5 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 5 Washington, D. C. 20549 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ( X ) Check here if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ( X ) Form 3 Holdings Reported ( X ) Form 4 Transactions Reported - ------------------------------------------------------------------------------------------------------------------------------------ | | | | |1 Name and Address of Reporting Person * |2 Issuer Name and Ticker/Trading Symbol|6 Relationship of Reporting | | | | Person(s) to Issuer | | Rosen Jonathan |Biopharmaceutics, Inc. BOPM | (Check All Applicable) | | |---------------------------------------| ( X ) Director ( X ) 10% Owner| | (Last) (First) (Middle)|3 IRS or Social |4 Statement for | ( X ) Officer ( ) Other | | | Security Number | Month/Year | (Give Title below) (Specify below)| | c/o Biopharmaceutics, Inc. | of Reporting | | | | (Street 1) | Person | 03/08/1999 | President and Chief Executive Off. | | | (Voluntary) |---------------------|------------------------------------| | 990 Station Road | |5 If Amendment, |7 Individual or Joint/Group Filing | | (Street 2) | | Date of Original | (Check Applicable) | | | | (Month/Year) | Form filed by: | | Bellport NY 11713 | | | (X) One Reporting Person | | (City) (State) (Zip) | | | ( ) More Than One Reporting Person| - ------------------------------------------------------------------------------------------------------------------------------------ Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ |1 Title of Security |2 Trans- |3 Trans- |4 Securities Acquired |5 Amount of |6 Ownership|7 Nature of Indirect | | (Instruction 3) | action | action | (A) or Disposed of (D) | Securities | Form: | Beneficial Ownership | | | Date | Code | (Instructions 3, 4, 5) | Beneficially | Direct (D)| (Instruction 4) | | | (Month/ |(Instr 8)|------------------------| Owned at End | or | | | | Day/ | | Amount |(A)| Price | of Issuer's |Indirect(I)| | | | Year) | | |(D)| | Fiscal Year | (Instr 4) | | |--------------------------------|----------|---------|-----------|---|--------|--------------|-----------|------------------------| |Common Stock | 10/21/96| J1 | 47,500*| A| $1.11**| | I |I/N/O a cmpany which is | | | | | | | | | |owned by Jonathan Rosen'| | | | | | | | | |s trust. | - ------------------------------------------------------------------------------------------------------------------------------------ |Common Stock | 1/18/99| J2 | 3333333| A| $.18| | I |I/N/O Dynamic Corporate | | | | | | | | | |Holdings Corp., a BVI co| | | | | | | | | |rp, of which Rosen owns | | | | | | | | | |50% | - ------------------------------------------------------------------------------------------------------------------------------------ |Common Stock | 1/18/99| J | 500,000| A| $.18| 3880833| D | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 2270 (7-96)
FORM 5 (Continued) - ------------------------------------------------------------------------------------------------------------------------------------ Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (Puts, Calls, Warrants, Options, Convertible Securities) - ------------------------------------------------------------------------------------------------------------------------------------ | | | | | | | | | | | | |1 Title of |2 Con- |3 Trans-|4 Trans-|5 Number of |6 Date |7 Title and Amount|8 Price |9 Number|10 Own-|11 Nature| | Derivative | ver- | action | action | Derivative | Exercisable and | of Underlying | of |of Deri-|ership:| of | | Security | sion | Date | Code | Securities | Expiration Date | Securities | Deri- |vative |Direct |Indirect | | (Instr 3) | or | (Month/| (Instr | Acquired (A) or | (Month/Day/Year)|(Instructions 3,4)| vative |Secur- |(D) or |Ownership| | | Exer- | Day/ | 8) | Disposed of (D) |-----------------|------------------| Sec- |ties |Indi- |(Instr 4)| | | cise | Year) | |(Instrs 3, 4, 5) | Date | Expir- | |Amount | urity |Owned at|rect(I)| | | | Price | |--------|-----------------| Exer- | ation | Title |or Num- |(Instr |End of |(Instr | | | | | | | (A) | (D) | cisable| Date | |ber of | 5) |Year | 4) | | | | | | | | | | | |Shares | |(Instr4)| | | |------------|--------|--------|--------|--------|--------|--------|--------|---------|--------|--------|--------|-------|---------| |None | | | | | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: *- Reflects one for four reverse stock split **-Price reflects one for four reverse stock split J1 - Payment for services rendered J2 - Private Placement Jonathan Rosen 3/8/99 _____________________________________ ___________ ** Signature of Reporting Person Date ** Intentional misstatement or ommissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: Transmit one copy of this Form to EDGAR, using a typed signature. If space is insufficient, see Intruction 6 for procedure. SEC 2270 (7-96)
-----END PRIVACY-ENHANCED MESSAGE-----